Expansion of product offerings with focus on cancer therapeutics drives M&A activity
India market sees no deals in August ‘13
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Piramal Healthcare to invest $11 million at its UK facility
Work on the new suite, which will house formulation, packaging coating and tableting equipment, will commence at the end of 2013
PSM India organises workshops on pharmacovigilance
Stakeholders across the spectrum deliberated on the current state of pharmacovigilance and ways to make the system stronger.…
National Forum on Tuberculosis holds first meeting in New Delhi
Discusses the rise and challenges of drug-resistant TB in India
OPPI seminar debates healthcare access in India
The event saw the presence of distinguished professionals, acclaimed experts and scientists from the Indian healthcare industry…
UK seeks to create healthy business environment with India
13 British pharma, life sciences and research organisations on a business visit to India
Safeguarding products is top challenge for Asia’s healthcare executives: Survey
Product security rises to top spot while regulatory compliance remains top concern
US FDA approves first generic capecitabine of Teva Pharmaceuticals
To treat colorectal and breast cancers
Debiopharm Group in research agreement with TCG Lifesciences
To develop a novel class of antibiotics, a new strategic therapeutic area for Debiopharm
WHO evaluates Panacea Biotec’s pentavalent vaccine
Successfully completes the audit of its Lalru and Baddi facilities, conducted by WHO team